Question 1

What specific aspects of my quality of life will be monitored during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer clinical trial (NCT02842294). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will I need to come in for assessments or treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer clinical trial (NCT02842294). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Bevacizumab that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer clinical trial (NCT02842294). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this study compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer clinical trial (NCT02842294). Contact the study team or your healthcare provider for specific answers.

Question 5

What support will be available to help manage any side effects I experience?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer clinical trial (NCT02842294). Contact the study team or your healthcare provider for specific answers.

What this study is about